Home > Insider Trading > Geron Corp

Geron Corp (GERN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
41 - 50
Next >>

Johnson & Johnson (JNJ)'s Janssen Builds On Partnership With Geron Corporation (GERN)

Janssen Pharmaceuticals, a subsidiary of the giant manufacturing company, Johnson & Johnson (NYSE:JNJ) has expanded the current partnership with the long-beleaguered Geron Corporation (NASDAQ:GERN).

Keep Reading →

September 21st, 2016 - News Stock Analysis

Why Isle of Capri Casinos (ISLE) and KB Home (KBH) Are Among Today's Gaining Stocks

Stock markets around the world rebounded with rise in oil prices and gains in commodity markets.

Keep Reading →

September 19th, 2016 - Market Movers News

Polaris, Syntel: Why These 5 Stocks Are Making Big Moves Today

Among the stocks showing a great deal of movement today are Polaris Industries Inc.

Keep Reading →

September 12th, 2016 - Market Movers News

Here is What Hedge Funds Think About Geron Corporation (GERN)

Is Geron Corporation (NASDAQ:GERN) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research.

Keep Reading →

November 27th, 2015 - Hedge Funds News

Geron Corporation (GERN) And Lannett Company, Inc. (LCI): Two Pharmaceutical Stocks Making Big Gains For Very Different Reasons

Shares of both Geron Corporation (NASDAQ:GERN) and Lannett Company, Inc.

Keep Reading →

September 3rd, 2015 - Hedge Funds News

Wayne Holman's Hedge Fund Takes 5.8% Stake in Geron

Wayne Holman, Geron Corporation: This morning, Wayne Holman's hedge fund Ridgeback Capital Management reported adding Geron Corporation (NASDAQ:GERN) to its equity portfolio through purchasing a passive...

Keep Reading →

October 17th, 2013 - Hedge Funds News

Aratana Therapeutics Inc (PETX), Geron Corporation (GERN), Kythera Biopharmaceuticals Inc (KYTH): Humongous Health-Care Stocks This Week

The only news from Aratana Therapeutics Inc (NASDAQ:PETX) this week, though, stemmed from the company's presentation at the Stifel Nicolaus Weisel Healthcare Conference in Boston on Wednesday.

Keep Reading →

September 15th, 2013 - News

Should You Buy Pacific Biosciences of California (PACB)?

To the average investor, there are tons of metrics shareholders can use to analyze Mr. Market. A duo of the best are hedge fund and insider trading interest.

Keep Reading →

September 15th, 2013 - News